• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by.

作者信息

Tønder J E, Olesen P H, Hansen J B, Begtrup M, Pettersson I

机构信息

Health Care Discovery, Novo Nordisk A/S, Måløv, Denmark.

出版信息

J Comput Aided Mol Des. 2001 Mar;15(3):247-58. doi: 10.1023/a:1008140021426.

DOI:10.1023/a:1008140021426
PMID:11289078
Abstract

A study of a series of compounds with agonistic effect at the alpha4beta2 nicotinic acetylcholine receptors resulted in an improved pharmacophore model as well as a CoMFA model. The pharmacophore was composed of three pharmacophoric elements: (1) a site point (a) corresponding to a protonated nitrogen atom, (2) a site point (b) corresponding to an electronegative atom capable of forming a hydrogen bond, and (3) the centre of a heteroaromatic ring or a C=O bond (c). The pharmacophoric elements were related by the following parameters: (a-b) 7.3-8.0 A, (a-c) 6.5-7.4 A, and the angle between the two distance vectors (delta bac) 30.4-35.8 degrees. In addition to this, a stereoselective CoMFA model was developed, which showed good predictability even for compound classes not present in the training set.

摘要

相似文献

1
An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by.
J Comput Aided Mol Des. 2001 Mar;15(3):247-58. doi: 10.1023/a:1008140021426.
2
Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling.α4β2烟碱型乙酰胆碱受体激动剂:构效关系与分子模拟
Curr Med Chem. 2001 May;8(6):651-74. doi: 10.2174/0929867013373165.
3
Neuronal nicotinic acetylcholine receptor agonists: pharmacophores, evolutionary QSAR and 3D-QSAR models.神经元烟碱型乙酰胆碱受体激动剂:药效基团、进化定量构效关系及三维定量构效关系模型
Curr Top Med Chem. 2004;4(3):335-60. doi: 10.2174/1568026043451384.
4
Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.
J Comput Aided Mol Des. 2001 Sep;15(9):859-72. doi: 10.1023/a:1013115717587.
5
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.
Curr Med Chem. 2002 Jan;9(1):1-29. doi: 10.2174/0929867023371463.
6
[3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain.
Eur J Pharmacol. 1987 Jul 23;139(3):323-33. doi: 10.1016/0014-2999(87)90590-5.
7
3D-QSAR and QSSR studies of 3,8-diazabicyclo[4.2.0]octane derivatives as neuronal nicotinic acetylcholine receptors by comparative molecular field analysis (CoMFA).通过比较分子场分析(CoMFA)对3,8-二氮杂双环[4.2.0]辛烷衍生物作为神经元烟碱型乙酰胆碱受体进行3D-QSAR和QSSR研究。
Bioorg Med Chem Lett. 2009 Jan 1;19(1):127-31. doi: 10.1016/j.bmcl.2008.11.016. Epub 2008 Nov 9.
8
Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.新型乙酰胆碱和氨甲酰胆碱类似物:一种功能选择性α4β2烟碱型乙酰胆碱受体激动剂的研发
J Med Chem. 2008 Dec 11;51(23):7380-95. doi: 10.1021/jm701625v.
9
Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models.
Curr Top Med Chem. 2004;4(6):631-44. doi: 10.2174/1568026043451122.
10
Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.取代 1,2,3-三唑作为 α7 烟碱型乙酰胆碱受体激动剂的选择性优化。
ACS Chem Neurosci. 2015 Aug 19;6(8):1317-30. doi: 10.1021/acschemneuro.5b00058. Epub 2015 May 15.

引用本文的文献

1
Differential Activation and Desensitization States Promoted by Noncanonical 7 Nicotinic Acetylcholine Receptor Agonists.非经典 7 型烟碱型乙酰胆碱受体激动剂诱导的激活和脱敏状态的差异。
J Pharmacol Exp Ther. 2022 Nov;383(2):157-171. doi: 10.1124/jpet.122.001354. Epub 2022 Sep 2.
2
Merging old and new perspectives on nicotinic acetylcholine receptors.融合烟碱型乙酰胆碱受体的新旧观点。
Biochem Pharmacol. 2014 May 1;89(1):1-11. doi: 10.1016/j.bcp.2014.01.029. Epub 2014 Jan 31.
3
Computational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor.

本文引用的文献

1
Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.
J Med Chem. 1999 Dec 2;42(24):4970-80. doi: 10.1021/jm9910627.
2
2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.2-、5-和6-卤代-3-(2(S)-氮杂环丁烷甲氧基)吡啶:合成、对烟碱型乙酰胆碱受体的亲和力及分子模拟
J Med Chem. 1998 Sep 10;41(19):3690-8. doi: 10.1021/jm980170a.
3
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.作为药物研发靶点的神经元烟碱型乙酰胆碱受体
杂环和构象受限的埃皮卡丁类似物在神经元烟碱型乙酰胆碱受体中结合能力的计算分析。
Mol Divers. 2010 May;14(2):201-11. doi: 10.1007/s11030-009-9161-9. Epub 2009 May 29.
4
Multiple pharmacophores for the selective activation of nicotinic alpha7-type acetylcholine receptors.用于选择性激活烟碱型α7 型乙酰胆碱受体的多种药效基团。
Mol Pharmacol. 2008 Dec;74(6):1496-511. doi: 10.1124/mol.108.048892. Epub 2008 Sep 2.
5
Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniques.使用非线性技术对单季铵盐和双季铵盐作为α4β2烟碱型乙酰胆碱受体亚型配体进行分子建模。
AAPS J. 2005 Oct 25;7(3):E678-85. doi: 10.1208/aapsj070368.
6
Identifying the binding mode of a molecular scaffold.确定分子支架的结合模式。
J Comput Aided Mol Des. 2004 Jan;18(1):23-40. doi: 10.1023/b:jcam.0000022561.76694.5b.
7
Epibatidine: impact on nicotinic receptor research.埃皮巴蒂啶:对烟碱受体研究的影响。
Cell Mol Neurobiol. 2003 Jun;23(3):365-78. doi: 10.1023/a:1023692705700.
8
Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.
J Comput Aided Mol Des. 2001 Sep;15(9):859-72. doi: 10.1023/a:1013115717587.
J Med Chem. 1997 Dec 19;40(26):4169-94. doi: 10.1021/jm970377o.
4
Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.表小檗碱的合成及其烟碱样活性:一种埃博霉素的异恶唑类似物。
Eur J Pharmacol. 1997 Feb 26;321(2):189-94. doi: 10.1016/s0014-2999(96)00939-9.
5
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.对中枢神经元烟碱型乙酰胆碱受体具有亚纳摩尔亲和力的新型3-吡啶基醚。
J Med Chem. 1996 Feb 16;39(4):817-25. doi: 10.1021/jm9506884.
6
Epibatidine, a potent analgetic and nicotinic agonist.
Mol Pharmacol. 1994 Apr;45(4):563-9.
7
Structure and activity of acetylcholine.乙酰胆碱的结构与活性。
Nature. 1970 Dec 5;228(5275):917-22. doi: 10.1038/228917a0.
8
The ensemble approach to distance geometry: application to the nicotinic pharmacophore.距离几何的集成方法:在烟碱药效团中的应用。
J Med Chem. 1986 Jun;29(6):899-906. doi: 10.1021/jm00156a005.
9
Anatoxin-a a potent ligand for nicotinic cholinergic receptors in rat brain.
Eur J Pharmacol. 1987 Mar 31;135(3):457-8. doi: 10.1016/0014-2999(87)90702-3.
10
Stereoselectivity of nicotinic receptors.
Prog Brain Res. 1989;79:95-100. doi: 10.1016/s0079-6123(08)62468-1.